LAUSR

Although the current methods of pharmaceutical care have demonstrably improved pathogenic condition and humanistic health outcomes of patients with type 2 diabetes, lacking humanistic care limits its reach and effectiveness. The purpose of this study was to evaluate the effectiveness of daily humanistic care reminders in pharmaceutical care of patients with type 2 diabetes. A total of 1200 patients with type 2 diabetes were recruited. The control group received only pharmaceutical care, whereas the intervention group received extra humanistic care from clinical pharmacists. Biochemical data, levels of quality of life, satisfaction, and self-care behavior and relationships between humanistic care and glycemic control were collected before and after 12-month intervention. Humanistic care increased levels of quality of life, satisfaction, self-efficacy and self-care behavior score, decreased blood pressure, glycosylated hemoglobin A1c (HbA1c), blood lipid, fasting blood glucose, postprandial 2-h blood glucose (PPG), inflammation, and insulin resistance after 12-month follow up. Humanistic care showed a positive correlation with glycemic control and negative relationship with HbA1c in patients with type 2 diabetes. There was a positive correlation between humanistic care and glycemic control (R = 0.641, P < .01) and a negative relationship between humanistic care and HbA1c in patients with type 2 diabetes (r = −0.482, P < .01). In conclusion, humanistic care could improve the control of overall clinical outcomes and enhanced medication adherences, which play an important role in the management of patients with type 2 diabetes.